{"issuance_frequency":"","notes_translated":{"fr":"Le Relevé des maladies transmissibles au Canada est une publication bilingue et libre d'accès revue par un comité de lecture portant sur la prévention et le contrôle des maladies infectieuses nouvelles et tenaces.","en":"The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"P1M","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","metadata_created":"2020-10-07T19:52:23.662308","subject":["health_and_safety"],"date_modified":"2020-09-23 00:00:00","pspc_identification_number":"","metadata_modified":"2020-10-07T20:21:59.071462","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2020-10-07","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["éclosions de maladies infectieuses","recrues militaires","Canada","Streptococcus pyogenes","prophylaxie aux antibiotiques de masse","éclosions de maladies infectieuses","recrues militaires","Canada","Streptococcus pyogenes","prophylaxie antibiotique de masse","événements indésirables","infections transmissibles sexuellement","Forces armées canadiennes","recrues militaires","comportements à risque","utilisation de condoms","nombre de partenaires sexuels","COVID-19","Direction de la protection de la santé de la Force","ministère de la Défense nationale","intervention en cas de pandémie","coronavirus","surveillance","Forces armées canadiennes","santé publique","militaire","gonorrhée","chlamydia","TAAN","extragénital","pharynx","rectum","expositions en laboratoire","incidents de laboratoire","infections contractées en laboratoire","agents pathogènes humains et toxines","surveillance","déclaration des incidents en laboratoire au Canada","Centre de biosûreté","Comité consultatif national de l’immunisation","CCNI","VIH","vaccin vivant atténué contre l’influenza","examen de la documentation","vaccin","indemnisation","assurance sans égard à la faute","considérations éthiques"],"en":["Infectious disease outbreaks","military recruits","Canada","Streptococcus pyogenes","mass antibiotic prophylaxis","infectious disease outbreaks","military recruits","Canada","Streptococcus pyogenes","mass antibiotic prophylaxis","adverse events","sexually transmitted infections","Canadian Armed Forces","military recruits","risk behaviours","condom use","number of sexual partners","COVID-19","Directorate of Force Health Protection","Department of National Defence","pandemic response","coronavirus","surveillance","Canadian Armed Forces","public health","military","gonorrhea","chlamydia","NAAT","extragenital","pharynx","rectum","laboratory exposures","laboratory incidents","laboratory-acquired infections","human pathogens and toxins","surveillance","Laboratory Incident Notification Canada","Centre for Biosecurity","National Advisory Committee on Immunization","NACI","HIV","live attenuated influenza vaccine","literature review","vaccine injury","compensation","no-fault insurance","ethical considerations"]},"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"RMTC : Volume 46–9- septembre 2020 : Protection de la santé des Forces","en":"CCDR: Volume 46-9-September 2020: Force Health Protection"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"1deafc58-fb6e-442a-b096-9928d48d3163","related_relationship":"","name_translated":{"fr":"RMTC : Volume 46–9- septembre 2020 : Protection de la santé des Forces","en":"CCDR: Volume 46-9-September 2020: Force Health Protection"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 46-9-September 2020: Force Health Protection","language":["en"],"created":"2020-10-07T19:52:23.825113","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr.html","last_modified":null,"position":0,"revision_id":"c582689b-96c9-42b9-a2bc-bfdf651308c6","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"5dd73f30-1dab-421b-83d6-582af1372a91","related_relationship":"","name_translated":{"fr":"RMTC : Volume 46–9- septembre 2020 : Protection de la santé des Forces","en":"CCDR: Volume 46-9-September 2020: Force Health Protection"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 46-9-September 2020: Force Health Protection","language":["fr"],"created":"2020-10-07T19:52:23.825119","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc.html","last_modified":null,"position":1,"revision_id":"c582689b-96c9-42b9-a2bc-bfdf651308c6","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"500a875b-64a5-435a-af79-ad4ce930af94","related_relationship":"","name_translated":{"fr":"RMTC : Volume 46–9- septembre 2020 : Protection de la santé des Forces","en":"CCDR: Volume 46-9-September 2020: Force Health Protection"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 46-9-September 2020: Force Health Protection","language":["en"],"created":"2020-10-07T19:52:23.825122","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-sept-3-2020/ccdrv46i09-eng.pdf","last_modified":null,"position":2,"revision_id":"c582689b-96c9-42b9-a2bc-bfdf651308c6","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"5fffc8fa-f54b-4da5-997c-c3174daf70cc","related_relationship":"","name_translated":{"fr":"RMTC : Volume 46–9- septembre 2020 : Protection de la santé des Forces","en":"CCDR: Volume 46-9-September 2020: Force Health Protection"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 46-9-September 2020: Force Health Protection","language":["fr"],"created":"2020-10-07T19:52:23.825124","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-sept-3-2020/ccdrv46i09f-fra.pdf","last_modified":null,"position":3,"revision_id":"c582689b-96c9-42b9-a2bc-bfdf651308c6","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"d33d2b5f-d78b-4b7d-b6fc-031b0967409a","related_relationship":"","name_translated":{"fr":"Système militaire de soins de santé du Canada","en":"Public health practice within Canada’s military healthcare system"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Public health practice within Canada’s military healthcare system","language":["en"],"created":"2020-10-07T19:52:23.825126","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-september-3-2020/canada-military-healthcare-system.html","last_modified":null,"position":4,"revision_id":"c582689b-96c9-42b9-a2bc-bfdf651308c6","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"569e24ff-7e3f-4a43-a64d-f4df143ca756","related_relationship":"","name_translated":{"fr":"Système militaire de soins de santé du Canada","en":"Public health practice within Canada’s military healthcare system"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Public health practice within Canada’s military healthcare system","language":["fr"],"created":"2020-10-07T19:52:23.825127","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-9-3-septembre-2020/systeme-militaire-soins-sante-canada.html","last_modified":null,"position":5,"revision_id":"c582689b-96c9-42b9-a2bc-bfdf651308c6","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"f6a74523-e856-42cf-96fc-b83e27dddb6c","related_relationship":"","name_translated":{"fr":"Système militaire de soins de santé du Canada","en":"Public health practice within Canada’s military healthcare system"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Public health practice within Canada’s military healthcare system","language":["en"],"created":"2020-10-07T19:52:23.825129","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-sept-3-2020/ccdrv46i09a01-eng.pdf","last_modified":null,"position":6,"revision_id":"c582689b-96c9-42b9-a2bc-bfdf651308c6","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"51b7e48b-daa7-4516-9089-448a3ddf8aea","related_relationship":"","name_translated":{"fr":"Système militaire de soins de santé du Canada","en":"Public health practice within Canada’s military healthcare system"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Public health practice within Canada’s military healthcare system","language":["fr"],"created":"2020-10-07T19:52:23.825131","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-sept-3-2020/ccdrv46i09a01f-fra.pdf","last_modified":null,"position":7,"revision_id":"c582689b-96c9-42b9-a2bc-bfdf651308c6","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"e1066b68-b07e-452a-80b0-2cb98918d716","related_relationship":"","name_translated":{"fr":"Trois éclosions séquentielles de streptocoque du groupe A sur une période de deux ans à l’École de leadership et de recrues des Forces canadiennes, Garnison Saint-Jean, Québec","en":"Three sequential outbreaks of Group A Streptococcus over a two-year period at the Canadian Forces Leadership and Recruit School, St. Jean Garrison, Québec"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Three sequential outbreaks of Group A Streptococcus over a two-year period at the Canadian Forces Leadership and Recruit School, St. Jean Garrison, Québec","language":["en"],"created":"2020-10-07T19:52:23.825133","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-september-3-2020/group-a-streptococcus-outbreak-quebec.html","last_modified":null,"position":8,"revision_id":"c582689b-96c9-42b9-a2bc-bfdf651308c6","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"45cb5f86-e6d4-4ff2-84c4-166e926fdd4a","related_relationship":"","name_translated":{"fr":"Trois éclosions séquentielles de streptocoque du groupe A sur une période de deux ans à l’École de leadership et de recrues des Forces canadiennes, Garnison Saint-Jean, Québec","en":"Three sequential outbreaks of Group A Streptococcus over a two-year period at the Canadian Forces Leadership and Recruit School, St. Jean Garrison, Québec"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Three sequential outbreaks of Group A Streptococcus over a two-year period at the Canadian Forces Leadership and Recruit School, St. Jean Garrison, Québec","language":["fr"],"created":"2020-10-07T19:52:23.825135","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-9-3-septembre-2020/eclosion-streptocoque-groupe-a-quebec.html","last_modified":null,"position":9,"revision_id":"c582689b-96c9-42b9-a2bc-bfdf651308c6","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"abb75f35-0e5a-4e50-9602-7f16979f31c3","related_relationship":"","name_translated":{"fr":"Trois éclosions séquentielles de streptocoque du groupe A sur une période de deux ans à l’École de leadership et de recrues des Forces canadiennes, Garnison Saint-Jean, Québec","en":"Three sequential outbreaks of Group A Streptococcus over a two-year period at the Canadian Forces Leadership and Recruit School, St. Jean Garrison, Québec"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Three sequential outbreaks of Group A Streptococcus over a two-year period at the Canadian Forces Leadership and Recruit School, St. Jean Garrison, Québec","language":["en"],"created":"2020-10-07T19:52:23.825137","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-sept-3-2020/ccdrv46i09a02-eng.pdf","last_modified":null,"position":10,"revision_id":"c582689b-96c9-42b9-a2bc-bfdf651308c6","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"b916a5a8-ccea-4469-a4c7-8cda7ef91ee8","related_relationship":"","name_translated":{"fr":"Trois éclosions séquentielles de streptocoque du groupe A sur une période de deux ans à l’École de leadership et de recrues des Forces canadiennes, Garnison Saint-Jean, Québec","en":"Three sequential outbreaks of Group A Streptococcus over a two-year period at the Canadian Forces Leadership and Recruit School, St. Jean Garrison, Québec"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Three sequential outbreaks of Group A Streptococcus over a two-year period at the Canadian Forces Leadership and Recruit School, St. Jean Garrison, Québec","language":["fr"],"created":"2020-10-07T19:52:23.825139","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-sept-3-2020/ccdrv46i09a02f-fra.pdf","last_modified":null,"position":11,"revision_id":"c582689b-96c9-42b9-a2bc-bfdf651308c6","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"88978ea8-858a-4ec8-a359-ca943aaa338d","related_relationship":"","name_translated":{"fr":"Événements indésirables à la suite d’une prophylaxie antibiotique de masse pendant une éclosion de streptocoque du groupe A à l’École de leadership et de recrues des Forces canadiennes","en":"Adverse events following mass antibiotic prophylaxis during a Group A Streptococcus outbreak in the Canadian Forces Leadership and Recruit School"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Adverse events following mass antibiotic prophylaxis during a Group A Streptococcus outbreak in the Canadian Forces Leadership and Recruit School","language":["en"],"created":"2020-10-07T19:52:23.825140","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-september-3-2020/mass-antibiotic-prophylaxis-group-a-streptococcus-outbreak.html","last_modified":null,"position":12,"revision_id":"c582689b-96c9-42b9-a2bc-bfdf651308c6","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"baae2150-5749-4527-a7a0-f693c771f926","related_relationship":"","name_translated":{"fr":"Événements indésirables à la suite d’une prophylaxie antibiotique de masse pendant une éclosion de streptocoque du groupe A à l’École de leadership et de recrues des Forces canadiennes","en":"Adverse events following mass antibiotic prophylaxis during a Group A Streptococcus outbreak in the Canadian Forces Leadership and Recruit School"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Adverse events following mass antibiotic prophylaxis during a Group A Streptococcus outbreak in the Canadian Forces Leadership and Recruit School","language":["fr"],"created":"2020-10-07T19:52:23.825142","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-9-3-septembre-2020/antibioprophylaxie-mass-eclosion-streptocoque-groupe-a.html","last_modified":null,"position":13,"revision_id":"c582689b-96c9-42b9-a2bc-bfdf651308c6","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"5ef6334c-8a97-4566-834a-abe36dc3d8e7","related_relationship":"","name_translated":{"fr":"Événements indésirables à la suite d’une prophylaxie antibiotique de masse pendant une éclosion de streptocoque du groupe A à l’École de leadership et de recrues des Forces canadiennes","en":"Adverse events following mass antibiotic prophylaxis during a Group A Streptococcus outbreak in the Canadian Forces Leadership and Recruit School"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Adverse events following mass antibiotic prophylaxis during a Group A Streptococcus outbreak in the Canadian Forces Leadership and Recruit School","language":["en"],"created":"2020-10-07T19:52:23.825144","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-sept-3-2020/ccdrv46i09a03-eng.pdf","last_modified":null,"position":14,"revision_id":"c582689b-96c9-42b9-a2bc-bfdf651308c6","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"bdee88f2-8c2d-4f41-b154-e85e723520a3","related_relationship":"","name_translated":{"fr":"Événements indésirables à la suite d’une prophylaxie antibiotique de masse pendant une éclosion de streptocoque du groupe A à l’École de leadership et de recrues des Forces canadiennes","en":"Adverse events following mass antibiotic prophylaxis during a Group A Streptococcus outbreak in the Canadian Forces Leadership and Recruit School"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Adverse events following mass antibiotic prophylaxis during a Group A Streptococcus outbreak in the Canadian Forces Leadership and Recruit School","language":["fr"],"created":"2020-10-07T19:52:23.825146","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-sept-3-2020/ccdrv46i09a03f-fra.pdf","last_modified":null,"position":15,"revision_id":"c582689b-96c9-42b9-a2bc-bfdf651308c6","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"044d5507-0d90-49e4-80e3-757df76c8c1e","related_relationship":"","name_translated":{"fr":"Tendances des infections transmissibles sexuellement prémilitaires et des comportements à risque associés chez les recrues des Forces armées canadiennes","en":"Trends in pre-military sexually transmitted infections and associated risk behaviours in Canadian Armed Forces recruits"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Trends in pre-military sexually transmitted infections and associated risk behaviours in Canadian Armed Forces recruits","language":["en"],"created":"2020-10-07T19:52:23.825148","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-september-3-2020/sexually-transmitted-infections-canadian-armed-forces.html","last_modified":null,"position":16,"revision_id":"c582689b-96c9-42b9-a2bc-bfdf651308c6","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"8798aeca-f9c2-456b-967d-5b62feaa0748","related_relationship":"","name_translated":{"fr":"Tendances des infections transmissibles sexuellement prémilitaires et des comportements à risque associés chez les recrues des Forces armées canadiennes","en":"Trends in pre-military sexually transmitted infections and associated risk behaviours in Canadian Armed Forces recruits"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Trends in pre-military sexually transmitted infections and associated risk behaviours in Canadian Armed Forces recruits","language":["fr"],"created":"2020-10-07T19:52:23.825150","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-9-3-septembre-2020/infections-transmissibles-sexuellement-forces-armees-canadiennes.html","last_modified":null,"position":17,"revision_id":"c582689b-96c9-42b9-a2bc-bfdf651308c6","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"4f011406-fee9-4b69-b74f-dab227d04187","related_relationship":"","name_translated":{"fr":"Tendances des infections transmissibles sexuellement prémilitaires et des comportements à risque associés chez les recrues des Forces armées canadiennes","en":"Trends in pre-military sexually transmitted infections and associated risk behaviours in Canadian Armed Forces recruits"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Trends in pre-military sexually transmitted infections and associated risk behaviours in Canadian Armed Forces recruits","language":["en"],"created":"2020-10-07T20:02:09.517773","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-sept-3-2020/ccdrv46i09a04-eng.pdf","last_modified":null,"position":18,"revision_id":"486437b3-aa52-4e95-a9bc-2882eb53dd49","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"eb14fe4c-08bd-4f53-94c7-f3ffffbc9ea3","related_relationship":"","name_translated":{"fr":"Tendances des infections transmissibles sexuellement prémilitaires et des comportements à risque associés chez les recrues des Forces armées canadiennes","en":"Trends in pre-military sexually transmitted infections and associated risk behaviours in Canadian Armed Forces recruits"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Trends in pre-military sexually transmitted infections and associated risk behaviours in Canadian Armed Forces recruits","language":["fr"],"created":"2020-10-07T20:02:09.517779","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-sept-3-2020/ccdrv46i09a04f-fra.pdf","last_modified":null,"position":19,"revision_id":"486437b3-aa52-4e95-a9bc-2882eb53dd49","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"278892c9-4a64-4c55-bad8-0d56b5e256e1","related_relationship":"","name_translated":{"fr":"Rôle de la Direction de la protection de la santé de la Force dans la réponse des Forces armées canadiennes à la pandémie de COVID-19","en":"The role of Force Health Protection in the Canadian Armed Forces’ response to the COVID-19 pandemic"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"The role of Force Health Protection in the Canadian Armed Forces’ response to the COVID-19 pandemic","language":["en"],"created":"2020-10-07T20:02:09.517781","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-september-3-2020/force-health-protection-canadian-armed-forces-response-pandemic.html","last_modified":null,"position":20,"revision_id":"486437b3-aa52-4e95-a9bc-2882eb53dd49","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"f110dc23-3514-4cf7-b792-e70634689806","related_relationship":"","name_translated":{"fr":"Rôle de la Direction de la protection de la santé de la Force dans la réponse des Forces armées canadiennes à la pandémie de COVID-19","en":"The role of Force Health Protection in the Canadian Armed Forces’ response to the COVID-19 pandemic"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"The role of Force Health Protection in the Canadian Armed Forces’ response to the COVID-19 pandemic","language":["fr"],"created":"2020-10-07T20:02:09.517784","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-9-3-septembre-2020/protection-sante-forces-cadre-reaction-forces-armees-canadiennes-pandemie.html","last_modified":null,"position":21,"revision_id":"486437b3-aa52-4e95-a9bc-2882eb53dd49","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"fe48b8b5-6b4c-4187-8d2a-e0ac8a9e3311","related_relationship":"","name_translated":{"fr":"Rôle de la Direction de la protection de la santé de la Force dans la réponse des Forces armées canadiennes à la pandémie de COVID-19","en":"The role of Force Health Protection in the Canadian Armed Forces’ response to the COVID-19 pandemic"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"The role of Force Health Protection in the Canadian Armed Forces’ response to the COVID-19 pandemic","language":["en"],"created":"2020-10-07T20:02:09.517785","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-sept-3-2020/ccdrv46i09a05-eng.pdf","last_modified":null,"position":22,"revision_id":"486437b3-aa52-4e95-a9bc-2882eb53dd49","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"c0c65726-b925-4e02-8317-7fdf85850c3f","related_relationship":"","name_translated":{"fr":"Rôle de la Direction de la protection de la santé de la Force dans la réponse des Forces armées canadiennes à la pandémie de COVID-19","en":"The role of Force Health Protection in the Canadian Armed Forces’ response to the COVID-19 pandemic"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"The role of Force Health Protection in the Canadian Armed Forces’ response to the COVID-19 pandemic","language":["fr"],"created":"2020-10-07T20:02:09.517787","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-sept-3-2020/ccdrv46i09a05f-fra.pdf","last_modified":null,"position":23,"revision_id":"486437b3-aa52-4e95-a9bc-2882eb53dd49","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"6cd49746-9f6b-4bff-bc64-834f49cb713c","related_relationship":"","name_translated":{"fr":"Infographie : Enquête sur l’éclosion de maladies d’origine alimentaire du 21 avril 2018","en":"Infographic: Foodborne illness outbreak investigation of April 21st 2018 (Exercise Maple Resolve 2018)"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Infographic: Foodborne illness outbreak investigation of April 21st 2018 (Exercise Maple Resolve 2018)","language":["en"],"created":"2020-10-07T20:02:09.517789","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-september-3-2020/infographic-outbreak-investigation-foodborne-illness-2018.html","last_modified":null,"position":24,"revision_id":"486437b3-aa52-4e95-a9bc-2882eb53dd49","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"d4b68fd1-0742-42bd-b46c-fc2404eb7951","related_relationship":"","name_translated":{"fr":"Infographie : Enquête sur l’éclosion de maladies d’origine alimentaire du 21 avril 2018","en":"Infographic: Foodborne illness outbreak investigation of April 21st 2018 (Exercise Maple Resolve 2018)"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Infographic: Foodborne illness outbreak investigation of April 21st 2018 (Exercise Maple Resolve 2018)","language":["fr"],"created":"2020-10-07T20:02:09.517791","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-9-3-septembre-2020/infographie-eclosion-maladies-origine-alimentaire.html","last_modified":null,"position":25,"revision_id":"486437b3-aa52-4e95-a9bc-2882eb53dd49","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"91df12ce-8dd1-4ae4-92f7-4def4de2ae56","related_relationship":"","name_translated":{"fr":"Infographie : Enquête sur l’éclosion de maladies d’origine alimentaire du 21 avril 2018","en":"Infographic: Foodborne illness outbreak investigation of April 21st 2018 (Exercise Maple Resolve 2018)"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Infographic: Foodborne illness outbreak investigation of April 21st 2018 (Exercise Maple Resolve 2018)","language":["en"],"created":"2020-10-07T20:02:09.517793","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-sept-3-2020/ccdrv46i09a05a-eng.pdf","last_modified":null,"position":26,"revision_id":"486437b3-aa52-4e95-a9bc-2882eb53dd49","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"d47b5be1-628d-4b64-92ab-4a35090f79ae","related_relationship":"","name_translated":{"fr":"Infographie : Enquête sur l’éclosion de maladies d’origine alimentaire du 21 avril 2018","en":"Infographic: Foodborne illness outbreak investigation of April 21st 2018 (Exercise Maple Resolve 2018)"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Infographic: Foodborne illness outbreak investigation of April 21st 2018 (Exercise Maple Resolve 2018)","language":["fr"],"created":"2020-10-07T20:02:09.517795","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-sept-3-2020/ccdrv46i09a05af-fra.pdf","last_modified":null,"position":27,"revision_id":"486437b3-aa52-4e95-a9bc-2882eb53dd49","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"4d178e2d-bcfc-4509-8156-ddd784190936","related_relationship":"","name_translated":{"fr":"Infographie:  Surveillance à l’aide de marqueurs d’éclosion pour les opérations de déploiement des Forces armées canadiennes (FAC), 2017 à 2019","en":"Infographic: Surveillance using outbreak markers for Canadian Armed Forces (CAF) deployed operations, 2017–2019"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Infographic: Surveillance using outbreak markers for Canadian Armed Forces (CAF) deployed operations, 2017–2019","language":["en"],"created":"2020-10-07T20:02:09.517797","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-september-3-2020/acute-respiratory-tract-infection-gastrotestinal-infections-2017-2019.html","last_modified":null,"position":28,"revision_id":"486437b3-aa52-4e95-a9bc-2882eb53dd49","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"e2626502-e456-4ec7-8dbc-a8652fc93343","related_relationship":"","name_translated":{"fr":"Infographie:  Surveillance à l’aide de marqueurs d’éclosion pour les opérations de déploiement des Forces armées canadiennes (FAC), 2017 à 2019","en":"Infographic: Surveillance using outbreak markers for Canadian Armed Forces (CAF) deployed operations, 2017–2019"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Infographic: Surveillance using outbreak markers for Canadian Armed Forces (CAF) deployed operations, 2017–2019","language":["fr"],"created":"2020-10-07T20:02:09.517799","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-9-3-septembre-2020/infection-aigue-voies-respiratoires-infections-gastro-intestinales-2017-2019.html","last_modified":null,"position":29,"revision_id":"486437b3-aa52-4e95-a9bc-2882eb53dd49","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"180e2f3c-8633-4aa2-9fee-2880dbb6ae96","related_relationship":"","name_translated":{"fr":"Infographie:  Surveillance à l’aide de marqueurs d’éclosion pour les opérations de déploiement des Forces armées canadiennes (FAC), 2017 à 2019","en":"Infographic: Surveillance using outbreak markers for Canadian Armed Forces (CAF) deployed operations, 2017–2019"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Infographic: Surveillance using outbreak markers for Canadian Armed Forces (CAF) deployed operations, 2017–2019","language":["en"],"created":"2020-10-07T20:02:09.517800","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-sept-3-2020/ccdrv46i09a05b-eng.pdf","last_modified":null,"position":30,"revision_id":"486437b3-aa52-4e95-a9bc-2882eb53dd49","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"79aad316-3ccf-40e2-a555-a83d172d5fe8","related_relationship":"","name_translated":{"fr":"Infographie:  Surveillance à l’aide de marqueurs d’éclosion pour les opérations de déploiement des Forces armées canadiennes (FAC), 2017 à 2019","en":"Infographic: Surveillance using outbreak markers for Canadian Armed Forces (CAF) deployed operations, 2017–2019"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Infographic: Surveillance using outbreak markers for Canadian Armed Forces (CAF) deployed operations, 2017–2019","language":["fr"],"created":"2020-10-07T20:02:09.517802","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-sept-3-2020/ccdrv46i09a05bf-fra.pdf","last_modified":null,"position":31,"revision_id":"486437b3-aa52-4e95-a9bc-2882eb53dd49","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"859794aa-a789-4db3-8d9c-a33981154937","related_relationship":"","name_translated":{"fr":"Infographie : Occurrence et traitement des expositions aux animaux liées à la rage chez le personnel des Forces armées canadiennes","en":"Infographic: Occurrence and treatment of rabies-related animal exposures among Canadian Armed Forces personnel"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Infographic: Occurrence and treatment of rabies-related animal exposures among Canadian Armed Forces personnel","language":["en"],"created":"2020-10-07T20:02:09.517804","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-september-3-2020/canadian-armed-forces-exposure-rabies.html","last_modified":null,"position":32,"revision_id":"486437b3-aa52-4e95-a9bc-2882eb53dd49","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"77bc51e2-d0d0-4b2f-9df1-d76b3fd5236d","related_relationship":"","name_translated":{"fr":"Infographie : Occurrence et traitement des expositions aux animaux liées à la rage chez le personnel des Forces armées canadiennes","en":"Infographic: Occurrence and treatment of rabies-related animal exposures among Canadian Armed Forces personnel"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Infographic: Occurrence and treatment of rabies-related animal exposures among Canadian Armed Forces personnel","language":["fr"],"created":"2020-10-07T20:02:09.517806","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-9-3-septembre-2020/exposition-forces-armees-canadiennes-rage.html","last_modified":null,"position":33,"revision_id":"486437b3-aa52-4e95-a9bc-2882eb53dd49","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"17d7c6a4-3654-4306-b9a1-ce06c98f7df9","related_relationship":"","name_translated":{"fr":"Infographie : Occurrence et traitement des expositions aux animaux liées à la rage chez le personnel des Forces armées canadiennes","en":"Infographic: Occurrence and treatment of rabies-related animal exposures among Canadian Armed Forces personnel"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Infographic: Occurrence and treatment of rabies-related animal exposures among Canadian Armed Forces personnel","language":["en"],"created":"2020-10-07T20:11:59.817033","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-sept-3-2020/ccdrv46i09a05c-eng.pdf","last_modified":null,"position":34,"revision_id":"e88a0191-1ea6-4aa3-ae9f-322757ca0b1c","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"5ff10c86-21bf-4fd3-a8f6-8368a8794558","related_relationship":"","name_translated":{"fr":"Infographie : Occurrence et traitement des expositions aux animaux liées à la rage chez le personnel des Forces armées canadiennes","en":"Infographic: Occurrence and treatment of rabies-related animal exposures among Canadian Armed Forces personnel"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Infographic: Occurrence and treatment of rabies-related animal exposures among Canadian Armed Forces personnel","language":["fr"],"created":"2020-10-07T20:11:59.817039","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-sept-3-2020/ccdrv46i09a05cf-fra.pdf","last_modified":null,"position":35,"revision_id":"e88a0191-1ea6-4aa3-ae9f-322757ca0b1c","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"096afb07-3348-4e68-8122-868b6465bf81","related_relationship":"","name_translated":{"fr":"Les tests de dépistage extragénitaux augmentent la détection des cas de gonorrhée et de chlamydia : Incidence de la mise en œuvre d’un test d’amplification de l’acide nucléique","en":"Extragenital testing increases case detection of gonorrhea and chlamydia: The impact of implementing nucleic acid amplification testing"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Extragenital testing increases case detection of gonorrhea and chlamydia: The impact of implementing nucleic acid amplification testing","language":["en"],"created":"2020-10-07T20:11:59.817041","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-september-3-2020/nucleic-acid-amplification-testing-gonorrhea-chlamydia.html","last_modified":null,"position":36,"revision_id":"e88a0191-1ea6-4aa3-ae9f-322757ca0b1c","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"b48fcbbe-1901-42af-9879-16ec8a26d878","related_relationship":"","name_translated":{"fr":"Les tests de dépistage extragénitaux augmentent la détection des cas de gonorrhée et de chlamydia : Incidence de la mise en œuvre d’un test d’amplification de l’acide nucléique","en":"Extragenital testing increases case detection of gonorrhea and chlamydia: The impact of implementing nucleic acid amplification testing"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Extragenital testing increases case detection of gonorrhea and chlamydia: The impact of implementing nucleic acid amplification testing","language":["fr"],"created":"2020-10-07T20:11:59.817043","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-9-3-septembre-2020/epreuve-amplification-acide-nucleique-gonorrhee-chlamydia.html","last_modified":null,"position":37,"revision_id":"e88a0191-1ea6-4aa3-ae9f-322757ca0b1c","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"95dd95bd-3942-43fc-8ce6-75ad41b7312c","related_relationship":"","name_translated":{"fr":"Les tests de dépistage extragénitaux augmentent la détection des cas de gonorrhée et de chlamydia : Incidence de la mise en œuvre d’un test d’amplification de l’acide nucléique","en":"Extragenital testing increases case detection of gonorrhea and chlamydia: The impact of implementing nucleic acid amplification testing"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Extragenital testing increases case detection of gonorrhea and chlamydia: The impact of implementing nucleic acid amplification testing","language":["en"],"created":"2020-10-07T20:11:59.817045","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-sept-3-2020/ccdrv46i09a06-eng.pdf","last_modified":null,"position":38,"revision_id":"e88a0191-1ea6-4aa3-ae9f-322757ca0b1c","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"c5e5d9c6-9159-4ac7-b315-b4a23661e3c1","related_relationship":"","name_translated":{"fr":"Les tests de dépistage extragénitaux augmentent la détection des cas de gonorrhée et de chlamydia : Incidence de la mise en œuvre d’un test d’amplification de l’acide nucléique","en":"Extragenital testing increases case detection of gonorrhea and chlamydia: The impact of implementing nucleic acid amplification testing"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Extragenital testing increases case detection of gonorrhea and chlamydia: The impact of implementing nucleic acid amplification testing","language":["fr"],"created":"2020-10-07T20:11:59.817047","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-sept-3-2020/ccdrv46i09a06f-fra.pdf","last_modified":null,"position":39,"revision_id":"e88a0191-1ea6-4aa3-ae9f-322757ca0b1c","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"9f140aa3-1e48-4658-b4d3-0203d9f8d19b","related_relationship":"","name_translated":{"fr":"Données sur les incidents d’exposition survenus dans des laboratoires au Canada en 2019","en":"Surveillance of laboratory exposures to human pathogens and toxins, Canada 2019"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Surveillance of laboratory exposures to human pathogens and toxins, Canada 2019","language":["en"],"created":"2020-10-07T20:11:59.817049","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-september-3-2020/data-laboratory-exposure-canada-2019.html","last_modified":null,"position":40,"revision_id":"e88a0191-1ea6-4aa3-ae9f-322757ca0b1c","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"87b6bfb9-96b5-4fe4-933b-a159611bf0c6","related_relationship":"","name_translated":{"fr":"Données sur les incidents d’exposition survenus dans des laboratoires au Canada en 2019","en":"Surveillance of laboratory exposures to human pathogens and toxins, Canada 2019"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Surveillance of laboratory exposures to human pathogens and toxins, Canada 2019","language":["fr"],"created":"2020-10-07T20:11:59.817051","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-9-3-septembre-2020/donnees-exposition-laboratoires-canada-2019.html","last_modified":null,"position":41,"revision_id":"e88a0191-1ea6-4aa3-ae9f-322757ca0b1c","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"d1af2764-a35f-4b04-b2fa-4cc9fc7ac0af","related_relationship":"","name_translated":{"fr":"Données sur les incidents d’exposition survenus dans des laboratoires au Canada en 2019","en":"Surveillance of laboratory exposures to human pathogens and toxins, Canada 2019"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Surveillance of laboratory exposures to human pathogens and toxins, Canada 2019","language":["en"],"created":"2020-10-07T20:11:59.817052","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-sept-3-2020/ccdrv46i09a07-eng.pdf","last_modified":null,"position":42,"revision_id":"e88a0191-1ea6-4aa3-ae9f-322757ca0b1c","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"7ff8915a-9d3e-4a12-a6de-084026030ef8","related_relationship":"","name_translated":{"fr":"Données sur les incidents d’exposition survenus dans des laboratoires au Canada en 2019","en":"Surveillance of laboratory exposures to human pathogens and toxins, Canada 2019"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Surveillance of laboratory exposures to human pathogens and toxins, Canada 2019","language":["fr"],"created":"2020-10-07T20:11:59.817054","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-sept-3-2020/ccdrv46i09a07f-fra.pdf","last_modified":null,"position":43,"revision_id":"e88a0191-1ea6-4aa3-ae9f-322757ca0b1c","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"ce078fe1-6c9c-4e9c-856d-190cc9344b66","related_relationship":"","name_translated":{"fr":"Résumé de l’examen systématique et de la recommandation du CCNI sur le recours au vaccin vivant atténué contre l’influenza (VVAI) chez les personnes infectées par le VIH","en":"Summary of the NACI systematic review and recommendation on the use of live attenuated influenza vaccine (LAIV) in HIV-infected individuals"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Summary of the NACI systematic review and recommendation on the use of live attenuated influenza vaccine (LAIV) in HIV-infected individuals","language":["en"],"created":"2020-10-07T20:11:59.817056","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-september-3-2020/national-advisory-committee-immunization-laiv-hiv-infected-individuals.html","last_modified":null,"position":44,"revision_id":"e88a0191-1ea6-4aa3-ae9f-322757ca0b1c","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"e9df971a-3372-4976-88a9-83487de596a7","related_relationship":"","name_translated":{"fr":"Résumé de l’examen systématique et de la recommandation du CCNI sur le recours au vaccin vivant atténué contre l’influenza (VVAI) chez les personnes infectées par le VIH","en":"Summary of the NACI systematic review and recommendation on the use of live attenuated influenza vaccine (LAIV) in HIV-infected individuals"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Summary of the NACI systematic review and recommendation on the use of live attenuated influenza vaccine (LAIV) in HIV-infected individuals","language":["fr"],"created":"2020-10-07T20:11:59.817058","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-9-3-septembre-2020/comite-consultatif-national-immunisation-vvai-personnes-infectees-vih.html","last_modified":null,"position":45,"revision_id":"e88a0191-1ea6-4aa3-ae9f-322757ca0b1c","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"11d678df-a2ad-4db1-b3a1-6e7b08304bf2","related_relationship":"","name_translated":{"fr":"Résumé de l’examen systématique et de la recommandation du CCNI sur le recours au vaccin vivant atténué contre l’influenza (VVAI) chez les personnes infectées par le VIH","en":"Summary of the NACI systematic review and recommendation on the use of live attenuated influenza vaccine (LAIV) in HIV-infected individuals"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Summary of the NACI systematic review and recommendation on the use of live attenuated influenza vaccine (LAIV) in HIV-infected individuals","language":["en"],"created":"2020-10-07T20:11:59.817060","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-sept-3-2020/ccdrv46i09a08-eng.pdf","last_modified":null,"position":46,"revision_id":"e88a0191-1ea6-4aa3-ae9f-322757ca0b1c","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"69c6eeda-60fd-415a-9640-b3f5f0e0948f","related_relationship":"","name_translated":{"fr":"Résumé de l’examen systématique et de la recommandation du CCNI sur le recours au vaccin vivant atténué contre l’influenza (VVAI) chez les personnes infectées par le VIH","en":"Summary of the NACI systematic review and recommendation on the use of live attenuated influenza vaccine (LAIV) in HIV-infected individuals"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Summary of the NACI systematic review and recommendation on the use of live attenuated influenza vaccine (LAIV) in HIV-infected individuals","language":["fr"],"created":"2020-10-07T20:11:59.817062","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-sept-3-2020/ccdrv46i09a08f-fra.pdf","last_modified":null,"position":47,"revision_id":"e88a0191-1ea6-4aa3-ae9f-322757ca0b1c","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"758c25ec-2810-47c1-8171-06ffd3cc2a52","related_relationship":"","name_translated":{"fr":"Programmes d’indemnisation des victimes d’une vaccination et situation au Québec","en":"Vaccine Injury Compensation Programs: Rationale and an overview of the Québec program"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Vaccine Injury Compensation Programs: Rationale and an overview of the Québec program","language":["en"],"created":"2020-10-07T20:11:59.817064","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-september-3-2020/vaccine-injury-compensation-programs-quebec.html","last_modified":null,"position":48,"revision_id":"e88a0191-1ea6-4aa3-ae9f-322757ca0b1c","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"cad03535-df85-4730-8c6e-34d260b6532c","related_relationship":"","name_translated":{"fr":"Programmes d’indemnisation des victimes d’une vaccination et situation au Québec","en":"Vaccine Injury Compensation Programs: Rationale and an overview of the Québec program"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Vaccine Injury Compensation Programs: Rationale and an overview of the Québec program","language":["fr"],"created":"2020-10-07T20:11:59.817066","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-9-3-septembre-2020/programmes-indemnisation-victimes-vaccination-quebec.html","last_modified":null,"position":49,"revision_id":"e88a0191-1ea6-4aa3-ae9f-322757ca0b1c","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"b47eda3a-0842-461d-9c88-1bf00d1d5a62","related_relationship":"","name_translated":{"fr":"Programmes d’indemnisation des victimes d’une vaccination et situation au Québec","en":"Vaccine Injury Compensation Programs: Rationale and an overview of the Québec program"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Vaccine Injury Compensation Programs: Rationale and an overview of the Québec program","language":["en"],"created":"2020-10-07T20:11:59.817068","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-sept-3-2020/ccdrv46i09a09-eng.pdf","last_modified":null,"position":50,"revision_id":"e88a0191-1ea6-4aa3-ae9f-322757ca0b1c","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"ea6623a1-e7cb-40f7-9ac4-617bc674a171","related_relationship":"","name_translated":{"fr":"Programmes d’indemnisation des victimes d’une vaccination et situation au Québec","en":"Vaccine Injury Compensation Programs: Rationale and an overview of the Québec program"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Vaccine Injury Compensation Programs: Rationale and an overview of the Québec program","language":["fr"],"created":"2020-10-07T20:12:08.693452","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-sept-3-2020/ccdrv46i09a09f-fra.pdf","last_modified":null,"position":51,"revision_id":"e906257d-acfb-4ba3-9f47-250101b505e9","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"7555eaba-50c6-4a8b-8596-d66327cf46f8","related_relationship":"","name_translated":{"fr":"La COVID-19 et les résidents de foyers de soins de longue durée; déclarations de l’ICMRA sur la confiance à l’égard des vaccins; le rapport annuel de 2018 sur la surveillance des maladies transmises par les moustiques et du virus du Nil occidental","en":"COVID-19 and residents in Long Term Care Homes; ICMRA Statements on Vaccine Confidence; 2018 Annual surveillance report on West Nile virus and other mosquito-borne diseases"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"COVID-19 and residents in Long Term Care Homes; ICMRA Statements on Vaccine Confidence; 2018 Annual surveillance report on West Nile virus and other mosquito-borne diseases","language":["en"],"created":"2020-10-07T20:21:59.148758","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-september-3-2020/id-news.html","last_modified":null,"position":52,"revision_id":"c1ff4a3b-dc3d-4622-b24d-864369b24e13","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"9fbf676d-8600-48ea-ad9b-2153cf2dc3b1","related_relationship":"","name_translated":{"fr":"La COVID-19 et les résidents de foyers de soins de longue durée; déclarations de l’ICMRA sur la confiance à l’égard des vaccins; le rapport annuel de 2018 sur la surveillance des maladies transmises par les moustiques et du virus du Nil occidental","en":"COVID-19 and residents in Long Term Care Homes; ICMRA Statements on Vaccine Confidence; 2018 Annual surveillance report on West Nile virus and other mosquito-borne diseases"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"COVID-19 and residents in Long Term Care Homes; ICMRA Statements on Vaccine Confidence; 2018 Annual surveillance report on West Nile virus and other mosquito-borne diseases","language":["fr"],"created":"2020-10-07T20:21:59.148763","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-9-3-septembre-2020/actualites-maladies-infectieuses.html","last_modified":null,"position":53,"revision_id":"c1ff4a3b-dc3d-4622-b24d-864369b24e13","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"a3514a2f-86b4-4bc3-9133-77734ee2feec","related_relationship":"","name_translated":{"fr":"La COVID-19 et les résidents de foyers de soins de longue durée; déclarations de l’ICMRA sur la confiance à l’égard des vaccins; le rapport annuel de 2018 sur la surveillance des maladies transmises par les moustiques et du virus du Nil occidental","en":"COVID-19 and residents in Long Term Care Homes; ICMRA Statements on Vaccine Confidence; 2018 Annual surveillance report on West Nile virus and other mosquito-borne diseases"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"COVID-19 and residents in Long Term Care Homes; ICMRA Statements on Vaccine Confidence; 2018 Annual surveillance report on West Nile virus and other mosquito-borne diseases","language":["en"],"created":"2020-10-07T20:21:59.148765","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-sept-3-2020/ccdrv46i09a10-eng.pdf","last_modified":null,"position":54,"revision_id":"c1ff4a3b-dc3d-4622-b24d-864369b24e13","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"2a9970b4-d98b-408f-ab78-da6cdc0ab5ca","related_relationship":"","name_translated":{"fr":"La COVID-19 et les résidents de foyers de soins de longue durée; déclarations de l’ICMRA sur la confiance à l’égard des vaccins; le rapport annuel de 2018 sur la surveillance des maladies transmises par les moustiques et du virus du Nil occidental","en":"COVID-19 and residents in Long Term Care Homes; ICMRA Statements on Vaccine Confidence; 2018 Annual surveillance report on West Nile virus and other mosquito-borne diseases"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"COVID-19 and residents in Long Term Care Homes; ICMRA Statements on Vaccine Confidence; 2018 Annual surveillance report on West Nile virus and other mosquito-borne diseases","language":["fr"],"created":"2020-10-07T20:21:59.148767","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-sept-3-2020/ccdrv46i09a10f-fra.pdf","last_modified":null,"position":55,"revision_id":"c1ff4a3b-dc3d-4622-b24d-864369b24e13","resource_type":"website"}],"place_of_publication":[],"num_resources":56,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Agence de la santé publique du Canada","en":"Public Health Agency of Canada"},"date_published":"2020-09-03 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:57.068700","title":"Public Health Agency of Canada | Agence de la santé publique du Canada","name":"phac-aspc","is_organization":true,"state":"active","image_url":"","revision_id":"96161da6-edc7-4d1d-99e0-baac9df7b3b9","type":"organization","id":"1C71053B-AA64-4646-956B-41631C396018","approval_status":"approved"},"name":"a03ba29a-7a12-49a9-8485-be9ba78bcffb","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases.","owner_org":"1C71053B-AA64-4646-956B-41631C396018","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"CCDR: Volume 46-9-September 2020: Force Health Protection","revision_id":"c582689b-96c9-42b9-a2bc-bfdf651308c6"}